Publication & Citation Trends
Publications
0 total
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
Cited by 0
Semantic Scholar
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study
Cited by 0
Semantic Scholar
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
Cited by 0
Semantic Scholar
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer
Cited by 5
Semantic Scholar
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Cited by 3
Semantic Scholar
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma OA
Cited by 11
Semantic Scholar
The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer.
Cited by 1
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(33)
Cancer Immunotherapy and Biomarkers
(29)
Bladder and Urothelial Cancer Treatments
(24)
Glioma Diagnosis and Treatment
(19)
Urinary and Genital Oncology Studies
(16)
Affiliations
University of Perugia
Santa Maria Nuova Hospital
Villa Maria Hospital
Azienda Ospedaliera di Perugia
Azienda Ospedaliera San Camillo-Forlanini